Opioid Pills. Opioid epidemic and drug abuse concept. Different tablets, pills, capsule on a pink background. Heap mix therapy drugs. Credit: Iryna Imago/Shutterstock.comMallinckrodt bankruptcy goes effective. On June 16, 2022, Mallinckrodt filed its Notice of Occurrence of Effective Date of Fourth Amended Joint Plan of Reorganization. Notice, In re Mallinckrodt PLC, et al., No. 20-12522 (Bankr. D. Del. June 16, 2022). The bankruptcy court had previously confirmed the bankruptcy plan on March 2, 2022. Opioid trusts were established in the bankruptcy plan to resolve all opioid claims. Id. From the effective date forward, the sole recourse of any opioid claimant based upon Mallinckrodt’s pre-effective date conduct will be to make a claim to the opioid trusts. Id. The opioids trusts will receive approximately $1.6 billion in structured payments from Mallinckrodt.

The case is In re Mallinckrodt PLC, No. 20-12522 (Bankr. D. Del.). The case is being decided by Bankruptcy Judge John Dorsey.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]